Εμφάνιση απλής εγγραφής

dc.creatorAgrawal R., MD FCRS, Betzler B., MBBS, Testi I., MD, Mahajan S., MBBS, Agarwal A., MS, Gunasekeran D.V., MD, Raje D., PhD, Aggarwal K., MS, Murthy S.I., DNB, Westcott M., FRCSOphth, Chee S.-P., FRCSEd, Mccluskey P., MD, Ho S.L., FRCSGlasg, Teoh S., FRCSEd, Cimino L., MD, Biswas J., MS, Narain S., MD, Agarwal M., MS, Mahendradas P., DNB, Khairallah M., MD, Jones N., FRCSOphth, Tugal-Tutkun I., MD, Babu K., DNB, Basu S., MS, Carreño E., MD, Lee R., PhD, Al-Dhibi H., MD, Bodaghi B., MD, Invernizzi A., MD, Goldstein D.A., MD, Herbort C.P., MD, Barisani-Asenbauer T., PhD, González-López J.J., PhD, Androudi S., MD, Bansal R., MS, Moharana B., MS, Esposti S., MD, Tasiopoulou A., MD, Nadarajah S., MD, Agarwal M., DNB, Abraham S., MD, Vala R., MD, Singh R., MS, Sharma A., MD, Sharma K., PhD, Zierhut M., PhD, Kon O.M., MRCP, Cunningham E.T., PhD, Kempen J.H., PhD, Nguyen Q.D., PhD, Pavesio C., FRCSOphth, Gupta V., MSen
dc.date.accessioned2023-01-31T07:30:32Z
dc.date.available2023-01-31T07:30:32Z
dc.date.issued2020
dc.identifier10.1080/09273948.2020.1761400
dc.identifier.issn09273948
dc.identifier.urihttp://hdl.handle.net/11615/70325
dc.description.abstractPurpose: The Collaborative Ocular Tuberculosis Study (COTS) Group sought to address the diagnostic uncertainty through retrospective cohort analysis of treatment regimens and therapeutic outcomes for patients with tubercular Anterior Uveitis (TAU) across international centers. Methods: Multicentre retrospective analysis of patients diagnosed with TAU between January 2004 to December 2014 that had a minimum follow-up of 1 year. Results: One hundred and sixty-five patients were included. One hundred and seven subjects received antitubercular therapy (ATT) (n = 107/165; 64.9%) with all the patients receiving topical steroid therapy. Treatment failure was noted in 17 patients (n = 17/165; 10.3%), more frequently described in patients that received ATT (n = 13/107, 12.2%), than those that did not receive ATT (n = 4/58, 6.9%). Conclusion: In this retrospective study, addition of ATT did not have any statistically significant impact on outcome in patients with TAU. © 2020, © 2020 Taylor & Francis Group, LLC.en
dc.language.isoenen
dc.sourceOcular Immunology and Inflammationen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85087505413&doi=10.1080%2f09273948.2020.1761400&partnerID=40&md5=ae1c4a436f8ff6df941f8754df37d588
dc.subjectsteroiden
dc.subjecttuberculostatic agenten
dc.subjectArticleen
dc.subjectclinical featureen
dc.subjectcohort analysisen
dc.subjectfemaleen
dc.subjectfollow upen
dc.subjecthumanen
dc.subjectiridocyclitisen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmulticenter studyen
dc.subjectocular tuberculosisen
dc.subjectrecurrence free survivalen
dc.subjectretrospective studyen
dc.subjectsteroid therapyen
dc.subjectsurvival analysisen
dc.subjecttime to treatmenten
dc.subjecttreatment failureen
dc.subjecttreatment outcomeen
dc.subjecttubercular anterior uveitisen
dc.subjectvisual acuityen
dc.subjectvisual impairmenten
dc.subjectTaylor and Francis Ltden
dc.titleThe Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitisen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής